265 related articles for article (PubMed ID: 11264189)
21. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.
Nicholas J
Front Biosci; 2007 Jan; 12():265-81. PubMed ID: 17127298
[TBL] [Abstract][Full Text] [Related]
22. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.
Suthaus J; Stuhlmann-Laeisz C; Tompkins VS; Rosean TR; Klapper W; Tosato G; Janz S; Scheller J; Rose-John S
Blood; 2012 May; 119(22):5173-81. PubMed ID: 22490805
[TBL] [Abstract][Full Text] [Related]
23. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
Kim B; Jeon YK; Kim CW
J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
25. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
27. Contribution of viral mimics of cellular genes to KSHV infection and disease.
Sakakibara S; Tosato G
Viruses; 2014 Sep; 6(9):3472-86. PubMed ID: 25243371
[TBL] [Abstract][Full Text] [Related]
28. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.
Sullivan RJ; Pantanowitz L; Casper C; Stebbing J; Dezube BJ
Clin Infect Dis; 2008 Nov; 47(9):1209-15. PubMed ID: 18808357
[TBL] [Abstract][Full Text] [Related]
29. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.
Parravicini C; Olsen SJ; Capra M; Poli F; Sirchia G; Gao SJ; Berti E; Nocera A; Rossi E; Bestetti G; Pizzuto M; Galli M; Moroni M; Moore PS; Corbellino M
Blood; 1997 Oct; 90(7):2826-9. PubMed ID: 9326251
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.
Giffin L; Yan F; Ben Major M; Damania B
J Virol; 2014 Aug; 88(16):9429-41. PubMed ID: 24920810
[TBL] [Abstract][Full Text] [Related]
31. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
[TBL] [Abstract][Full Text] [Related]
33. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.
Du MQ; Bacon CM; Isaacson PG
J Clin Pathol; 2007 Dec; 60(12):1350-7. PubMed ID: 18042691
[TBL] [Abstract][Full Text] [Related]
34. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.
Gaidano G; Castaños-Velez E; Biberfeld P
Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936
[TBL] [Abstract][Full Text] [Related]
35. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
[TBL] [Abstract][Full Text] [Related]
36. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
[TBL] [Abstract][Full Text] [Related]
37. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient.
Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I
Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 8 in hematologic diseases.
Mikala G; Xie J; Berencsi G; Kiss C; Márton I; Domján G; Vályi-Nagy I
Pathol Oncol Res; 1999; 5(1):73-9. PubMed ID: 10079383
[TBL] [Abstract][Full Text] [Related]
40. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
